Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1995 | 09-1995 | 06-1995 | 03-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,736 | 5,909 | 16,839 | 12,657 | 23,646 |
| Marketable Securities | 13,418 | 19,550 | 19,538 | 22,180 | 26,232 |
| Receivables | 2,689 | 4,519 | 2,410 | 2,399 | 0 |
| Other current assets | 359 | 585 | 669 | 655 | 2,168 |
| TOTAL | $49,202 | $30,563 | $39,456 | $37,891 | $52,046 |
| Non-Current Assets | |||||
| PPE Net | 42,274 | N/A | 37,829 | N/A | 37,523 |
| Investments And Advances | 14,742 | 16,184 | 15,545 | 0 | 11,280 |
| Other Non-Current Assets | 1,996 | 2,319 | 2,765 | 21,459 | 3,224 |
| TOTAL | $59,012 | $18,503 | $56,139 | $21,459 | $52,027 |
| Total Assets | $93,811 | $74,216 | $83,421 | $86,130 | $94,236 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 85 | 87 | 89 | 91 |
| Accounts payable and accrued liabilities | 6,290 | 4,327 | 4,641 | 3,708 | 4,971 |
| Accrued Expenses | 0 | 0 | 0 | 0 | 9,752 |
| Other current liabilities | 3,167 | 6,397 | 8,304 | 6,903 | 0 |
| TOTAL | $12,948 | $14,065 | $16,242 | $13,724 | $17,866 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,826 | 1,847 | 1,868 | 1,888 | 1,909 |
| aiOther Non-Current Liabilities | 103 | 78 | 52 | 38 | 0 |
| TOTAL | $13,007 | $7,110 | $7,757 | $8,624 | $9,299 |
| Total Liabilities | $25,955 | $21,175 | $23,999 | $22,348 | $27,165 |
| Shareholders' Equity | |||||
| Common Shares | 21 | 20 | 14 | 20 | 19 |
| Retained earnings | -124,605 | -116,795 | -109,649 | 0 | -101,098 |
| Other shareholders' equity | -1,154 | -1,438 | -2,018 | -107,284 | -763 |
| TOTAL | $67,856 | $53,041 | $59,422 | $63,782 | $67,071 |
| Total Liabilities And Equity | $93,811 | $74,216 | $83,421 | $86,130 | $94,236 |